Company / Gross Profit per Share
IRADIMED CORP Gross Profit per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$5.06
FY2025
5-year range
$2.41 / $5.06
FY2021-FY2025
Trend
+13.7%
vs FY2024
Sector context
#68 of 99
Health Care
What the data says
At $5.06, IRADIMED CORP's gross profit per share ranks #68 of 99 in the Health Care sector. Gross Profit per Share has increased for 5 consecutive years, from $2.00 in FY2020 to $5.06 in FY2025.
Based on SEC 10-K filings.
5.06 in FY2025 with a 5-year CAGR of +20.4%.
Improved from $3.98 to $5.06 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- +25.7%
- 5-Year CAGR
- +20.4%
- 10-Year CAGR
- -
Sector benchmark
#68 of 99 in Health CareTop 69% of 99This company $5.06 Sector average $13.98
▼
-63.8% below sector average
Key checks
Key Insights
- IRADIMED CORP's gross profit per share has grown for 5 consecutive years.
- In FY2025, gross profit per share increased 13.7% year-over-year.
- Ranks #68 out of 99 companies in the Health Care sector.
- Lowest gross profit per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 5.29 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.06 | +13.7% |
| FY2024 | $4.45 | +11.7% |
| FY2023 | $3.98 | +56.5% |
| FY2022 | $2.55 | +5.5% |
| FY2021 | $2.41 | +20.4% |
| FY2020 | $2.00 | -25.9% |
| FY2019 | $2.70 | +8.7% |
| FY2018 | $2.49 | +3.5% |
| FY2017 | $2.40 | +119.1% |
| FY2016 | $1.10 | -3.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026